Billiontoone Inc - Class A
Research Billiontoone Inc - Class A (BLLN) on Bullrun: market cap USD 4.69B, P/E 162.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBLLN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 4.69B
- P/E162.4
- Financial periodQ2 2026
- RevenueUSD 109.45M
- Net incomeUSD 8.05M
- Free cash flowUSD 5.09M
- Gross margin70.5%
Valuation Snapshot
latest market cap is USD 4.69B; P/E is 162.4.
Peer valuation comparison
Latest P/E is 162.43x versus a Healthcare sector median of 24.46x (564.1% above).
Latest P/E is 162.43x versus a United States median of 24.87x (553.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 305.11M | USD 7.45M | USD 15.71M | 68.3% | 0.14 | USD 495.98M | USD 57.23M | USD 480.11M |
| FY2024 | USD 152.58M | -USD 41.57M | -USD 46.78M | 53.0% | -4.12 | USD 191.48M | USD 51.48M | -USD 251.66M |
| FY2023 | USD 71.73M | -USD 82.68M | -USD 59.85M | 24.1% | -8.45 | USD 97.27M | n/a | -USD 219.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.69B | 162.4 | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.75B | n/a | n/a | n/a |
About Billiontoone Inc - Class A
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Billiontoone Inc - Class A's market cap?
Billiontoone Inc - Class A's market capitalization is USD 4.69B.
What is Billiontoone Inc - Class A's P/E ratio?
Billiontoone Inc - Class A's price-to-earnings (P/E) ratio is 162.4.
What does Billiontoone Inc - Class A do?
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.